Colin-Jones D G
Queen Alexandra Hospital, Portsmouth, England.
J Clin Gastroenterol. 1989;11 Suppl 1:S39-42.
The prevalence of Campylobacter pylori (CP) rises with age, as does gastritis. There is now convincing evidence that CP is causative in the majority of cases of active chronic gastritis and that its eradication substantially improves the severity of the gastritis, even back to normal in some cases. A small minority of people may have other factors causing their gastritis, bile reflux, or anti-inflammatory drugs, for example, CP causes temporary dyspeptic symptoms when an individual receives an acute infection for the first time, but what is much less certain is whether or not CP is responsible for chronic dyspeptic symptoms, and whether eradication of CP will improve dyspepsia. At present the therapeutic trials are too few and too small to be sure, but some individuals may benefit.
幽门螺杆菌(CP)的感染率随年龄增长而上升,胃炎也是如此。现在有确凿证据表明,在大多数活动性慢性胃炎病例中,CP是致病因素,根除CP可显著改善胃炎的严重程度,在某些情况下甚至可恢复正常。少数人可能有其他导致胃炎的因素,例如胆汁反流或抗炎药物。CP在个体首次发生急性感染时会引起暂时的消化不良症状,但CP是否导致慢性消化不良症状以及根除CP是否会改善消化不良,目前还很不确定。目前的治疗试验数量太少且规模太小,无法确定,但一些人可能会从中受益。